Moses KaneSharon Osbourne at the 2026 BRITs: Why Her Ozempic Story Is a Warning for Anyone Considering Weight-Loss Drugs
Sharon Osbourne appeared at the 2026 BRIT Awards in London alongside her daughter Kelly — and the images sparked immediate concern. Visibly frail following the death of her husband Ozzy Osbourne in July 2025, Sharon has become an inadvertent public face of a growing medical debate: what happens when weight-loss medication goes wrong, and when do you need a specialist?
The answer, doctors say, is sooner than most people think.
What Is Happening With Sharon Osbourne in 2026
Sharon Osbourne has been open about her use of Ozempic (semaglutide), a GLP-1 receptor agonist originally developed for type 2 diabetes management and now widely prescribed for weight loss. She publicly admitted losing 42 pounds on the drug — dropping to just 92 pounds at her lowest — before stopping, saying: "I didn't actually want to go this thin."
In 2026, health concerns have resurfaced. Sharon has stated publicly that she "can't gain weight after Ozempic use," indicating ongoing metabolic challenges. Her frail appearance at the 2026 BRITs prompted widespread commentary, with fans and health commentators alike asking whether she had resumed the medication.
Separately, Sharon announced in March 2026 that Ozzfest — the hard-rock festival she co-founded with Ozzy — will return in 2027 as a tribute to her late husband. A documentary, "The Osbournes: The Last Act," covering her final years with Ozzy, is also in post-production for a late 2026 streaming premiere.
The Ozempic Weight-Loss Phenomenon: What UK Doctors Are Seeing
Ozempic and its close relative Wegovy (a higher-dose semaglutide specifically licensed for obesity) have transformed weight-loss medicine in the UK. NHS England began rolling out Wegovy prescriptions in specialist clinics in 2024, and private prescriptions have surged since 2023.
But the drug's risks are real — and often underplayed in media coverage:
Muscle mass loss: One of the most significant concerns is that semaglutide causes loss of both fat and muscle. Without proper nutritional support and resistance training, patients can lose substantial lean mass — contributing to the "Ozempic face" phenomenon and, more seriously, to weakness, fatigue, and long-term metabolic problems.
Rebound weight gain: Studies show that most patients who stop Ozempic regain two-thirds of their lost weight within a year. For patients who lost weight without addressing underlying lifestyle factors, this rebound can be rapid and distressing.
Inability to regain weight after stopping: Less well-documented but increasingly reported — some patients find it difficult to regain healthy weight after extended use, as Sharon Osbourne has described. This can indicate altered metabolic set-points or persistent appetite suppression.
Psychological impact: Extreme weight loss, particularly in the context of grief (as in Sharon's case), can compound mental health challenges. GPs in the UK are increasingly flagging the intersection of eating disorder risk and GLP-1 medication use.
When to See a Specialist — Not Just a GP
One of the key lessons from high-profile cases like Sharon Osbourne's is that weight management is not a single-speciality problem. It sits at the intersection of endocrinology, nutrition, mental health, and — for older patients — geriatrics.
If you or someone you care about is considering Ozempic or Wegovy, or is experiencing side effects after stopping, these are the red flags that warrant specialist consultation rather than just a GP appointment:
- BMI falling below 18.5 (underweight threshold)
- Significant muscle weakness or loss of functional strength
- Persistent fatigue unrelated to sleep patterns
- Difficulty eating or sustained loss of appetite after stopping medication
- Mood changes, anxiety, or depressive episodes linked to body image
- Any pre-existing conditions (diabetes, cardiovascular disease, thyroid disorders) that interact with GLP-1 medications
In the UK, NHS specialist weight management clinics can assess the full picture. Private consultations with endocrinologists or dietitians can provide faster access and more tailored advice.
Grief, Weight, and the Complexity of Older Women's Health
Sharon Osbourne is 73 in 2026, navigating widowhood after 40 years with Ozzy. The intersection of grief and physical health in older women is an area where specialist care makes a measurable difference.
Research published in the BMJ in 2024 confirmed that bereavement significantly increases the risk of both unintentional weight loss and cardiovascular events in the 12 months following a spouse's death — particularly in women over 65. The NHS National Frailty Improvement Collaborative, rolling out across seven sites in England in 2026, specifically targets this group with proactive, personalised care pathways.
For families and carers watching an older relative lose weight rapidly following bereavement, the advice from UK geriatricians is consistent: don't wait for the situation to become critical. A geriatric assessment — available through NHS referral or private consultation — can identify the causes and recommend appropriate intervention.
What You Can Do Right Now
Sharon Osbourne's story — played out publicly across two decades of tabloid coverage — is a reminder that weight loss medication is a medical treatment, not a lifestyle product. The risks are real, the side effects can be lasting, and the need for specialist guidance is not optional.
Whether you're considering GLP-1 medication, managing its aftermath, or supporting someone whose weight has changed rapidly after loss, connecting with a qualified health professional is the right first step. On Expert Zoom, you can book online consultations with doctors and health specialists — without a waiting list.
Disclaimer: This article is for general information purposes only. Always consult a qualified healthcare professional before starting, stopping, or adjusting any prescription medication.
Sources: BRIT Awards 2026 – IBTimes UK, Ozzfest 2027 announcement – Hoodline, Sharon Osbourne Ozempic weight loss – IMDB, NHS National Frailty Collaborative 2026 – Age UK, Sharon Osbourne: I can't gain weight after Ozempic – Jerusalem Post
